Novo and Hims plan to announce a new partnership as soon as Monday, according to the person, who spoke on the condition of anonymity. The partnership is a surprising move for Novo, which sued Hims in February for launching a copycat version of its new Wegovy weight-loss pill. Novo’s willingness to partner with the telehealth platform now is a sign the drugmaker is under mounting pressure to regain its footing. Its partnerships with other telehealth companies, including Ro and Weight Watchers, have been less contentious. Ro, for example, was able to offer Novo’s Wegovy pill on its platform as soon as it became available in January.

Source: The Edge Markets March 07, 2026 06:44 UTC